Entries of Gabes, M. on the publication server
 | Up a level |
Jump to: 2021
Number of items: 4.
2021
Gabes, M. 
, Jourdan, C., Schramm, K., Masur, C., Abels, C., Kamudoni, P., Salek, S. and Apfelbacher, C.
(2021)
Hyperhidrosis Quality of Life Index (HidroQoL©): further validation and clinical application in patients with axillary hyperhidrosis using data from a phase III randomized controlled trial*.
British Journal of Dermatology 184 (3), pp. 473-481.
Fulltext not available.
, Jourdan, C., Schramm, K., Masur, C., Abels, C., Kamudoni, P., Salek, S. and Apfelbacher, C.
(2021)
Hyperhidrosis Quality of Life Index (HidroQoL©): further validation and clinical application in patients with axillary hyperhidrosis using data from a phase III randomized controlled trial*.
British Journal of Dermatology 184 (3), pp. 473-481.
Fulltext not available.
Gabes, M. and Apfelbacher, C.
(2021)
IDQoL, CDLQI and the 45‐item CADIS received a sufficient content validity rating during the HOME VII meeting in Japan: a group discussion study.
Journal of the European Academy of Dermatology and Venereology 35 (2), pp. 458-463.
Thomas, K. S. , Apfelbacher, C. A., Chalmers, J. R. , Simpson, E., Spuls, P. I., Gerbens, L. A. A. , Williams, H. C., Schmitt, J., Gabes, M., Howells, L., Stuart, B. L., Grinich, E., Pawlitschek, T., Burton, T., Howie, L., Gadkari, A., Eckert, L., Ebata, T., Boers, M., Saeki, H., Nakahara, T. and Katoh, N.
(2021)
Recommended core outcome instruments for health‐related quality of life, long‐term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting*.
British Journal of Dermatology 185 (1), pp. 139-146.
Fulltext not available.
, Apfelbacher, C. A., Chalmers, J. R. , Simpson, E., Spuls, P. I., Gerbens, L. A. A. , Williams, H. C., Schmitt, J., Gabes, M., Howells, L., Stuart, B. L., Grinich, E., Pawlitschek, T., Burton, T., Howie, L., Gadkari, A., Eckert, L., Ebata, T., Boers, M., Saeki, H., Nakahara, T. and Katoh, N.
(2021)
Recommended core outcome instruments for health‐related quality of life, long‐term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting*.
British Journal of Dermatology 185 (1), pp. 139-146.
Fulltext not available.
Gabes, M., Zeidler, C., Ständer, S., Chen, S. C. and Apfelbacher, C. J.
(2021)
Refinement and validation of the ItchyQoL using classical test theory and item response theory resulted in a reduction of the response categories from a 5‐point to a 3‐point scale.
British Journal of Dermatology 185 (3), pp. 548-554.
Fulltext not available.